The federal government is now operating on a Continuing Resolution through December 8, with a final funding bill for the new fiscal year yet to be determined by Congress. Over the summer, the House and Senate Appropriations Committees provided increases or flat funding for key IDSA and HIVMA priorities at the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration, Biomedical Advanced Research and Development Authority, State Department, and the US Agency for International Development.
While this was good news, Congress must still come up with a bipartisan budget agreement that provides relief from sequestration cuts and spending caps and then pass a final omnibus appropriations bill. IDSA is making the case for a bipartisan budget agreement and a final FY2018 omnibus funding bill. We recently urged House and Senate Appropriations Committee chairs and ranking members to move forward immediately and include robust resources for ID/HIV programs.
Additionally, Congress is currently negotiating final legislation to renew Department of Defense (DoD) programs for the next fiscal year. IDSA and HIVMA are concerned that provisions in the Senate version of the bill would severely restrict vital DoD ID/HIV research. IDSA and HIVMA are working to oppose these onerous restrictions.
Take Action to Protect Medical Research at DoD
We have told Congress about our opposition to these DoD provisions and we are urging IDSA and HIVMA members to do the same.
As the appropriations process presses on, IDSA and HIVMA will advocate for full funding for our priority programs across the federal government.
< Previous Article | Next Article >